Description
PT-141 peptides HubioPharm
PT-141 (Bremelanotide) is a synthetic peptide developed by the pharmaceutical company, Palatin Technologies, and distributed by HubioPharm. It is a melanocortin receptor agonist that works by stimulating the production and release of melanin in the body, leading to increased sexual arousal and improved sexual function.
PT-141 is used primarily for the treatment of sexual dysfunction, particularly in women with hypoactive sexual desire disorder (HSDD) and men with erectile dysfunction (ED). It is administered via injection, and its effects can last for several hours.
PT-141 is often referred to as the “female Viagra” due to its ability to enhance sexual desire and function in women. It has also shown potential for the treatment of other sexual disorders, such as premature ejaculation.
It’s important to note that the use of PT-141 should only be under the guidance of a medical professional and with proper monitoring of potential side effects. Common side effects of PT-141 include nausea, vomiting, headache, and flushing. More serious side effects can include high blood pressure, heart palpitations, and anxiety.
Reviews
There are no reviews yet.